US FDA Approved Jemincare to Initiate Clinical Trial of Neutralizing Antibody JMB2002 ...Middle East

SHANGHAI, April 2, 2021 /PRNewswire/ -- On March 31, 2021, Jemincare group announced that their anti-SARS-CoV-2 neutralizing antibody, JMB2002, independently developed by Jemincare Shanghai Research Center, was approved by FDA for clinical trial in the United States. Preclinical data...

Hence then, the article about us fda approved jemincare to initiate clinical trial of neutralizing antibody jmb2002 was published today ( Friday 02/04/2021 - 09:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( US FDA Approved Jemincare to Initiate Clinical Trial of Neutralizing Antibody JMB2002 )

Also on site :

• ‘Michael’ Director Antoine Fuqua On A Convo He Had With Michael Jackson, Reshoots, The Sequel & Choices Made About Pop Icon’s Controversies
• Donald Trump Tells ’60 Minutes’ About Moments Secret Service Scrambled To Get Him Out Of Hilton Ballroom: “I Wanted To See What Was Happening”
• Walmart's 'Incredibly Comfortable' $70 Corduroy Folding Sofa Is a Hosting Game-Changer and Comes in 4 Colors